Rapid PCR Value Target customers with rapid, lab-quality PCR capabilities at point-of-care. Position DASH Rapid PCR System as a fast, accurate, low hands-on-time solution for clinics, urgent care, and telemedicine hubs seeking same-day results.

Affordable Testing Emphasize cost-per-test advantages and total cost of ownership relative to traditional lab testing and antigen options. Highlight the potential savings for high-volume sites, emergency departments, and mobile testing fleets.

Multiplex Flexibility Capitalize on robust multiplexing across SARS-CoV-2 and influenza A/B and potential expansion to other pathogens. Propose bundled panels for seasonal respiratory testing to drive recurring orders.

Strategic Partnerships Leverage the merged entity with Minute Molecular Diagnostics to pursue co-selling with academic medical centers, private clinics, and occupational health programs. Present integration with existing workflows and minimal hands-on time as selling points for partnerships.

Financial Growth Highlight the recent funding and growth trajectory to reassure buyers about product viability and post-sale support. Offer scalable deployment options (pilot programs, STL-ready kits) to reduce purchase risk for mid-market customers.